Cargando…

Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials

OBJECTIVE: To verify the association of high-risk human papillomavirus (hrHPV) viral load reflected by cycle threshold (Ct) values from HPV testing on Cobas4800 assay with the histologic grades of cervical lesions via analysis on the combined data from two cervical cancer screening trials and to exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi, Du, Hui, Xiao, Aimin, Zhang, Wei, Wang, Chun, Huang, Xia, Qu, Xinfeng, Wang, Jianliu, Wu, Ruifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188717/ https://www.ncbi.nlm.nih.gov/pubmed/35690793 http://dx.doi.org/10.1186/s13027-022-00440-4

Ejemplares similares

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
por: Zhang, Yi, et al.
Publicado: (2023)

Cobas 4800 HPV detection in cervical samples of Polish women
por: Smolarz, Beata, et al.
Publicado: (2019)

The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples
por: Duan, Lyufang, et al.
Publicado: (2020)

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media
por: Luo, Hongxue, et al.
Publicado: (2016)

Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening
por: Yang, Qing, et al.
Publicado: (2022)

Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens
por: Martin, Isabella W., et al.
Publicado: (2012)

Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population
por: Liu, Stephanie S., et al.
Publicado: (2022)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening
por: Hwang, Sang-Hyun, et al.
Publicado: (2018)

HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
por: Frayle, Helena, et al.
Publicado: (2019)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru
por: Iwasaki, Ricardo, et al.
Publicado: (2014)

Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa
por: Dreyer, Greta, et al.
Publicado: (2019)

Comparison of the Cobas 4800 HPV Test and the Seeplex HPV4A ACE with the Hybrid Capture 2 Test
por: Ki, Eun Young, et al.
Publicado: (2012)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

High-Risk Human Papillomavirus Detection via Cobas(®) 4800 and REBA HPV-ID(®) Assays
por: Liewchalermwong, Sasiprapa, et al.
Publicado: (2022)

Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
por: Ki, Eun Young, et al.
Publicado: (2018)

Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears
por: Jun, Sun-Young, et al.
Publicado: (2015)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test
por: Lin, Chun-Qing, et al.
Publicado: (2017)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas(®) HBV Test for Use on the Cobas(®) 4800 System
por: Ortonne, Valérie, et al.
Publicado: (2021)

Application of the Cobas 4800 System for the Detection of High-Risk Human Papillomavirus in 5650 Asymptomatic Women
por: Wang, Shanyun, et al.
Publicado: (2020)

Comparative Performance of Anyplex II HPV28 and Cobas 4800 Human Papillomavirus (HPV) Assays for High-Risk HPV Detection in Self-collected Anal Samples
por: Delvallez, Gauthier, et al.
Publicado: (2023)

Sputasol (Dithiothreitol 0.54%) Improves the Detection of Human Papillomaviruses Using the Cobas 4800 System
por: Wang, Qing-Yong, et al.
Publicado: (2017)

Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test
por: Tranberg, Mette, et al.
Publicado: (2018)

Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening
por: Wang, Mengmeng, et al.
Publicado: (2020)

Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media
por: Jang, Dan, et al.
Publicado: (2021)

The performance of Cobas HPV test for cervical cancer screening in Chinese female migrant workers
por: He, Yaojuan, et al.
Publicado: (2021)

Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
por: Cai, Xushan, et al.
Publicado: (2019)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China
por: Song, Fangbin, et al.
Publicado: (2021)

HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer
por: Duan, Lyufang, et al.
Publicado: (2020)

Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening
por: Zhang, Wei, et al.
Publicado: (2020)

Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data
por: Song, Fangbin, et al.
Publicado: (2020)

Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination
por: Song, Fangbin, et al.
Publicado: (2022)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
por: Bell, Margo, et al.
Publicado: (2023)

Correction: HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

Clinician‐collected urethra swab: A good alternative sample type using cobas 4800 system for Chlamydia trachomatis and Neisseria gonorrhoeae in men
por: Wang, Qing‐Yong, et al.
Publicado: (2020)

Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests
por: Tardif, Keith D., et al.
Publicado: (2016)

Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV‐related cervical carcinogenesis
por: Zhang, Ruiyang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bv0mkla14q3l2enho8m97edqvv